Alcon AG (0A0D.IL) Stock Analysis & Winston Score
Alcon is the world's largest eye care device company. It makes surgical equipment and supplies used by eye doctors to perform cataract, glaucoma, and retinal surgeries. It also sells contact lenses and lens care products directly to consumers and eye care professionals. Alcon earns revenue through two main segments: surgical products (instruments, implantable lenses, and consumables) and vision care (contact lenses and solutions). The company is headquartered in Switzerland and sells its products in roughly 140 countries. Its scale, deep relationships with surgeons, and large installed base of surgical equipment create meaningful switching costs. Key growth drivers include aging global populations needing more eye surgeries and the adoption of premium intraocular lenses, though the company faces ongoing competition from other medical device makers and pricing pressure in certain markets.
Winston Score: 0/100 — Insufficient Data
Not enough data to score this stock reliably.
- Quality: Data not available (0/30)
- Growth: Data not available (0/20)
- Cash Flow: Data not available (0/10)
- Stability: Data not available (0/10)
- Valuation: Weak (1/10)
- Ownership: Ownership data not available (not counted) (0/15)
Key Facts
Price: 58.18 CHF
Market Cap: 28.4B CHF
Sector: Healthcare
Industry: Medical - Specialties
Exchange: International Order Book


